JAMES R. KASINGER, the General Counsel and Secretary of $CRSP, sold 3,182 shares of the company on 03-23-2026 for an estimated $148,853. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.3% of their shares of this class of stock. Following this trade, they now own 94,308 shares of this class of $CRSP stock.
$CRSP Insider Trading Activity
$CRSP insiders have traded $CRSP stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $CRSP stock by insiders over the last 6 months:
- SAMARTH KULKARNI (Chief Executive Officer) has made 0 purchases and 9 sales selling 182,271 shares for an estimated $10,756,932.
- RAJU PRASAD (Chief Financial Officer) has made 0 purchases and 10 sales selling 88,249 shares for an estimated $5,100,887.
- JAMES R. KASINGER (General Counsel and Secretary) has made 0 purchases and 5 sales selling 12,620 shares for an estimated $645,901.
- NAIMISH PATEL (Chief Medical Officer) sold 3,150 shares for an estimated $152,019
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRSP Hedge Fund Activity
We have seen 223 institutional investors add shares of $CRSP stock to their portfolio, and 227 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,437,220 shares (-43.8%) from their portfolio in Q4 2025, for an estimated $75,367,816
- ORBIS ALLAN GRAY LTD added 968,060 shares (+19.4%) to their portfolio in Q4 2025, for an estimated $50,765,066
- ARK INVESTMENT MANAGEMENT LLC added 735,084 shares (+7.5%) to their portfolio in Q4 2025, for an estimated $38,547,804
- MORGAN STANLEY removed 730,799 shares (-52.3%) from their portfolio in Q4 2025, for an estimated $38,323,099
- SQUAREPOINT OPS LLC added 581,108 shares (+inf%) to their portfolio in Q4 2025, for an estimated $30,473,303
- TWO SIGMA INVESTMENTS, LP removed 574,068 shares (-55.0%) from their portfolio in Q4 2025, for an estimated $30,104,125
- BLACKROCK, INC. added 458,033 shares (+6.5%) to their portfolio in Q4 2025, for an estimated $24,019,250
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRSP Analyst Ratings
Wall Street analysts have issued reports on $CRSP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/13/2026
- Citizens issued a "Market Outperform" rating on 01/30/2026
- Citigroup issued a "Buy" rating on 11/12/2025
- B of A Securities issued a "Buy" rating on 10/17/2025
To track analyst ratings and price targets for $CRSP, check out Quiver Quantitative's $CRSP forecast page.
$CRSP Price Targets
Multiple analysts have issued price targets for $CRSP recently. We have seen 11 analysts offer price targets for $CRSP in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Edward Tenthoff from Piper Sandler set a target price of $110.0 on 03/17/2026
- Geulah Livshits from Chardan Capital set a target price of $76.0 on 02/17/2026
- Tyler Van Buren from TD Cowen set a target price of $45.0 on 02/13/2026
- Liisa Bayko from Evercore ISI Group set a target price of $74.0 on 02/13/2026
- Gil Blum from Needham set a target price of $82.0 on 02/13/2026
- Silvan Turkcan from Citizens set a target price of $80.0 on 01/30/2026
- Yigal Nochomovitz from Citigroup set a target price of $77.0 on 11/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
